Liquidia (NASDAQ:LQDA) Reaches New 52-Week High – Here’s What Happened

Posted by Brian Himes on Aug 13th, 2026

Liquidia Corporation (NASDAQ:LQDA – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $92.36 and last traded at $91.03, with a volume of 1649881 shares changing hands. The stock had previously closed at $90.22.

Liquidia News Summary

Here are the key news stories impacting Liquidia this week:

Positive Sentiment: Liquidia reported second-quarter revenue of $171.7 million, up 1,842% year over year and slightly above the $168.5 million consensus estimate. YUTREPIA net product sales reached approximately $170.4 million, increasing 31% from the first quarter. Liquidia second-quarter financial results
Positive Sentiment: The company recorded its fourth consecutive quarter of rising profitability, posting $74.7 million in net income and $96.3 million in adjusted EBITDA. Cash increased to $284.2 million, supporting ongoing commercialization and clinical development. Liquidia Q2 net income and YUTREPIA sales
Positive Sentiment: Needham raised its price target from $70 to $110 and upgraded the stock to “Buy,” while BTIG increased its target from $109 to $111 and maintained a “Buy” rating. Lifesci Capital reaffirmed “Market Perform” with a $90 target. These revisions provide bullish support and imply meaningful upside from the reference price.
Neutral Sentiment: Management reaffirmed its goal of generating more than $1 billion in net revenue in 2027. However, research and development spending is expected to increase in the second half of 2026 as Liquidia advances the Phase 3 L606 program, which could temper near-term earnings growth.
Negative Sentiment: Diluted earnings per share were $0.74, below the MarketBeat consensus estimate of $0.76, even though they improved substantially from a $0.49 loss a year earlier. The miss appears to have outweighed the revenue beat for short-term traders. Liquidia shares after second-quarter earnings
Negative Sentiment: Investors may also be taking profits after a substantial prior rally. Quiver data shows 116 insider sales versus only one purchase over the past six months, a potential sentiment concern, while Liquidia’s elevated valuation leaves the stock sensitive to earnings surprises and increased spending.

Analyst Ratings Changes

LQDA has been the subject of several recent research reports. HC Wainwright set a $36.00 price objective on Liquidia in a report on Friday, July 24th. Zacks Research raised shares of Liquidia from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Needham & Company LLC lifted their price target on shares of Liquidia from $70.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday. BTIG Research boosted their price target on shares of Liquidia from $109.00 to $111.00 and gave the stock a “buy” rating in a research note on Wednesday. Finally, Wall Street Zen lowered shares of Liquidia from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 27th. Two research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $90.00.

View Our Latest Report on Liquidia

Liquidia Stock Down 10.5%

The business has a fifty day moving average of $78.22 and a 200 day moving average of $54.77. The company has a quick ratio of 2.03, a current ratio of 2.22 and a debt-to-equity ratio of 1.18. The firm has a market cap of $7.01 billion, a P/E ratio of 562.83 and a beta of 0.58.

Liquidia (NASDAQ:LQDA – Get Free Report) last issued its earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). The company had revenue of $171.68 million for the quarter, compared to the consensus estimate of $168.48 million. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.Liquidia’s quarterly revenue was up 1842.1% on a year-over-year basis. During the same quarter last year, the business posted ($0.49) EPS. On average, equities research analysts predict that Liquidia Corporation will post 3.02 EPS for the current year.

Insider Activity at Liquidia

In other Liquidia news, Director Paul B. Manning sold 200,000 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $63.91, for a total value of $12,782,000.00. Following the completion of the sale, the director owned 716,311 shares of the company’s stock, valued at approximately $45,779,436.01. This represents a 21.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stephen M. Bloch sold 242,269 shares of the stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $70.43, for a total transaction of $17,063,005.67. Following the completion of the sale, the director owned 1,176,184 shares in the company, valued at approximately $82,838,639.12. This trade represents a 17.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 1,781,861 shares of company stock worth $124,407,112 in the last three months. 25.60% of the stock is owned by insiders.

Institutional Trading of Liquidia

A number of large investors have recently made changes to their positions in the company. Covestor Ltd lifted its holdings in Liquidia by 41.9% during the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after acquiring an additional 359 shares in the last quarter. PNC Financial Services Group Inc. increased its holdings in shares of Liquidia by 7.2% in the fourth quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock worth $217,000 after acquiring an additional 422 shares in the last quarter. Quantinno Capital Management LP raised its position in shares of Liquidia by 3.6% during the first quarter. Quantinno Capital Management LP now owns 17,165 shares of the company’s stock worth $648,000 after purchasing an additional 589 shares during the period. Northwestern Mutual Wealth Management Co. acquired a new stake in shares of Liquidia during the fourth quarter worth about $25,000. Finally, ProShare Advisors LLC lifted its holdings in shares of Liquidia by 7.1% during the 4th quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock valued at $405,000 after purchasing an additional 775 shares in the last quarter. Institutional investors own 64.54% of the company’s stock.

About Liquidia

(Get Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).